FDA: Breast Implants Maybe Linked to Lymphoma

by: cancercompass

The Food and Drug Administration (FDA) recently announced that women with breast implants may have a small, but increased risk of developing anaplastic large cell lymphoma (ALCL).

The cancer isn't found in the breast tissue. Rather, the cancer is found in the fibrous capsule tissue, which abuts the breast tissue.

"Although the risk is quite small, we want women to be aware that there have been reports of ALCL occurring around saline and silicone gel-filled breast implants," Binita Ashar, M.D., and FDA Scientist stated in an FDA consumer update. "In the cases reported, ALCL was typically diagnosed years after the implant surgery. In most of these cases, the women were diagnosed after they observed changes in the look or feel of the area surrounding the implant."

Ashar further stated that women who have breast implants and no symptoms should continue to regularly monitor their implants and get breast screenings.

Women who have implants and notice pain or swelling around their implant should contact their physicians.

To learn more about the cancers featured in this article, please visit our lymphoma information page and our breast cancer information page.